Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress

被引:103
作者
Landriscina, M
Bagalá, C
Mandinova, A
Soldi, R
Micucci, I
Bellum, S
Prudovsky, I
Maciag, T
机构
[1] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA
[2] Univ Maine, Ctr Biophys Sci, Orono, ME 04469 USA
关键词
D O I
10.1074/jbc.M102925200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibroblast growth factor (FGF) 1 is known to be released in response to stress conditions as a component of a multiprotein aggregate containing the p40 extravescicular domain of p65 synaptotagmin (Syt) 1 and S100A13, Since FGF1 is a Cu2+-binding protein and Cu2+ is known to induce its dimerization, we evaluated the capacity of recombinant FGF1, p40 Syt1, and S100A13 to interact in a cell-free system and the role of Cu2+ in this interaction. We report that FGF1, p40 Syt1, and S100A13 are able to bind Cu2+ With Similar affinity and to interact in the presence of Cu2+ to form a multiprotein aggregate which is resistant to low concentrations of SDS and sensitive to reducing conditions and ultracentrifugation, The formation of this aggregate in the presence of Cu2+ is dependent on the presence of S100A13 and is mediated by cysteine-independent interactions between S100A13 and either FGF1 or p40 Syt1, Interestingly, S100A13 is also able to interact in the presence of Cu2+ with Cys-free FGF1 and this observation may account for the ability of S100A13 to export Cys-free FGF1 in response to stress. Lastly, tetrathiomolybdate, a Cu2+ chelator, significantly represses in a dose-dependent manner the heat shock-induced release of FGF1 and S100A13, These data suggest that S100A13 may be involved in the assembly of the multiprotein aggregate required for the release of FGF1 and that Cu2+ oxidation may be an essential post-translational intracellular modifier of this process.
引用
收藏
页码:25549 / 25557
页数:9
相关论文
共 39 条
[1]  
Bergmeyer H.-U., 1965, Methods of Enzymatic Analysis, P736
[2]   X-ray crystal structure of human acidic fibroblast growth factor [J].
Blaber, M ;
DiSalvo, J ;
Thomas, KA .
BIOCHEMISTRY, 1996, 35 (07) :2086-2094
[3]  
Brem, 1999, Cancer Control, V6, P436
[4]  
Brewer GJ, 2000, CLIN CANCER RES, V6, P1
[5]   Treatment of Wilson disease with ammonium tetrathiomolybdate .2. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy [J].
Brewer, GJ ;
Johnson, V ;
Dick, RD ;
Kluin, KJ ;
Fink, JK ;
Brunberg, JA .
ARCHIVES OF NEUROLOGY, 1996, 53 (10) :1017-1025
[6]   THE HEPARIN-BINDING (FIBROBLAST) GROWTH-FACTOR FAMILY OF PROTEINS [J].
BURGESS, WH ;
MACIAG, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :575-606
[7]   S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro [J].
Carreira, CM ;
LaVallee, TM ;
Tarantini, F ;
Jackson, A ;
Lathrop, JT ;
Hampton, B ;
Burgess, WH ;
Maciag, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) :22224-22231
[8]  
CARREIRA CM, 2001, IN PRESS GROWTH FACT
[9]   Disorders of copper transport [J].
Cox, DW .
BRITISH MEDICAL BULLETIN, 1999, 55 (03) :544-555
[10]   Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type [J].
Donato, R .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1999, 1450 (03) :191-231